Literature DB >> 31208894

Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB - Is one NUC better than the other?

Grace Lai-Hung Wong1, Pietro Lampertico2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31208894     DOI： 10.1016/j.jhep.2019.05.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

Review 2.  Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

Authors:  Terry Cheuk-Fung Yip; Jimmy Che-To Lai; Grace Lai-Hung Wong
Journal:  J Gastroenterol       Date:  2020-09-24       Impact factor: 7.527
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.